ANDR_HUMAN DHTR ELISA tesk kit
- Known as:
- ANDR_HUMAN DHTR Enzyme-linked immunosorbent assay test tesk reagent
- Catalog number:
- gen16141
- Product Quantity:
- 1
- Category:
- Peptides
- Supplier:
- Other suppliers
- Gene target:
- ANDR_HUMAN DHTR ELISA tesk kit
Related genes to: ANDR_HUMAN DHTR ELISA tesk kit
- Gene:
- AR NIH gene
- Name:
- androgen receptor
- Previous symbol:
- DHTR, SBMA
- Synonyms:
- AIS, NR3C4, SMAX1, HUMARA
- Chromosome:
- Xq12
- Locus Type:
- gene with protein product
- Date approved:
- 1986-01-01
- Date modifiied:
- 2014-11-19
Related products to: ANDR_HUMAN DHTR ELISA tesk kit
Related articles to: ANDR_HUMAN DHTR ELISA tesk kit
- Atrial cardiopathy is an important cause of embolic stroke and a potential cause of cognitive impairment. Increased left atrial volume indexed to body surface area (LAVi) has been widely used as a marker for atrial cardiopathy. However, because physiological remodeling, for example, due to exercise, may also increase LAVi, it lacks specificity. Left atrial to ventricular volume (LA:LV) ratio has been suggested as an improved marker of atrial cardiopathy, allowing detection of imbalanced, pathological atrial remodeling. We investigated if LA:LV ratio is associated with different sequelae of atrial cardiopathy. - Source: PubMed
Publication date: 2026/06/18
Deseoe JulianHänsel MartinHerzog LisaDavoudi NedaLuft Andreas RGebhard CatherineMenze BjoernSick BeateWegener Susanne - Recent observational studies have suggested that early treatment (<12 hours from diagnosis) of intermediate risk pulmonary embolism (PE) with catheter-based therapies may reduce morbidity and mortality. However, the effect of early versus late mechanical thrombectomy on acute pulmonary hemodynamics and right ventricular mechanics is less well defined. - Source: PubMed
Publication date: 2026/06/18
Bangalore SripalTomalty R DanaKado HermanSayfo SamehRaskin AdamQamar ArmanVargas Estrada AndresGarcia-Reyes KiremaLipshutz H GabrielYallapragada SrinivasButty SabahGandhi SagarDexter DavidTrivax JustinAli FarhanKnox MichaelRamos ChristopherAl-Saghir YoussefBishay Vivian - Liver transplantation (LT) provides the best long-term survival outcomes for patients with liver cancer. As a result, the field of transplant oncology has grown greatly over the past few decades, and many centers have expanded their criteria to allow increased access to LT for liver malignancies. Center-level guidelines and practices in transplant oncology significantly vary across the world, leading to debate regarding the best course of treatment for this patient population. An international consensus conference was convened by the International Liver Transplantation Society and the International Liver Cancer Association on February 1-2, 2024, in Valencia, Spain, to establish a more universal consensus regarding LT for oncologic indications. The conference followed the Delphi process, followed by external expert review. Consensus statements were accepted regarding patient assessment and waitlisting criteria, pretransplant treatment (including immunotherapy) and downstaging, living donor LT, post-LT patient management, and patient- and caregiver-related outcomes. The multidisciplinary participants in the consensus conference provided up-to-date recommendations regarding the selection and management of patients with liver cancer being considered for LT. Although participants deferred to center protocols in many cases, there was great interest in safely expanding access to LT for patients with larger tumor burden and biologically amenable lesions. - Source: PubMed
Publication date: 2026/04/25
Kodali SudhaKulik LauraD'Alessio AntonioDe Martin EleonoraHakeem Abdul RahmanLewinska MonicaLindsey StacieLiu KenMaravic ZoranaPatel Madhukar SPinato David JRammohan AshwinRich NicoleSanduzzi Zamparelli MarcoVictor David WVinaxia CarmenBrombosz Elizabeth WVillanueva AugustoMeyer TimSelzner NaziaGhobrial R MarkRela MohamedSapisochin Gonzalo - Employers and enrollees face premium growth and rising cost sharing, yet patients often don't know what they will owe when they seek care. Traditional "consumerism" has struggled because quality is hard to observe, prices are difficult to estimate in real time, and many services are urgent. We review the evolution of employer plan design, from broad network Preferred Provider Organizations (PPOs) to narrow and tiered networks, and reference pricing to the new emerging "dynamic copay" plans. These plans translate negotiated price variation into provider- and service-specific dollar copays displayed pre-service, often through app-based tools enabled by Centers for Medicare & Medicaid Services regulations, Transparency in Coverage data and AI-enabled analytics. Using UnitedHealthcare's Surest plan as an illustrative case, we examine the operational pre-requisites for "copay integrity," likely effects on out-of-pocket (OOP) predictability and spending in light of peer-reviewed evidence on tiered designs, and the constraints imposed by health insurance literacy, the limited share of spending that is meaningfully shoppable below the OOP maximum, and the long-run attenuation of steering effects. We conclude by proposing that pairing dynamic copays with reference pricing, layered onto a tiered network, may better address these limitations by strengthening steerage, improving OOP predictability and aligning member shopping incentives with higher-value care. - Source: PubMed
Publication date: 2026/06/16
Debbarma ArindamDowd Bryan E - Drought is the major abiotic stress limiting soybean growth and yield, yet accurately identifying genotypes that sustain yield under rainfed conditions remains a major bottleneck in soybean breeding. Canopy wilting scores are widely used as a proxy for evaluating plant responses to drought stress. However, most assessments rely on leaf-level visual observations that are inherently subjective and typically based on single time-point scores, providing only a snapshot of stress expression and failing to capture their relationship with yield retention under rainfed conditions. To address these limitations, this study used Unmanned Aerial Vehicle (UAV)-based high-throughput phenotyping at a single growth stage (R4/R5) as a more quantitative and objective alternative to visual scoring, with closer relevance to yield performance under drought conditions. From 2023 to 2025, a total of 85 soybean genotypes developed by soybean breeding programs in Arkansas, Missouri, Kansas, and North Carolina, along with commercial checks, were evaluated under irrigated and rainfed conditions in Stuttgart, Arkansas. Visual canopy wilting scores were recorded at R4/R5, along with vegetation indices captured using UAV-based multispectral imagery. UAV-derived indices showed significant correlations with yield ( = 0.22 to 0.45, p<0.05) under rainfed conditions. In contrast, visual canopy wilting scores displayed weak and inconsistent associations with yield ( = -0.28 to 0.35, p<0.05), suggesting limited ability to capture yield retention under rainfed conditions. Unsupervised -means clustering ( = 2) of UAV-derived vegetation indices separated genotypes into two distinct canopy response groups that were consistent across 2023 to 2025 rainfed seasons. Significant differences were observed among clusters for several vegetation indices (ARI, CIG, CIRE, GSAVI, GNDVI, GOSAVI, OSAVI, NDVI), indicating contrasting canopy stress responses. Under rainfed conditions, these UAV-defined clusters also differed for grain yield (2023: 1,925.6 1,703.1 kg/ha; 2024: 1,849.9 1,229.2 kg/ha; 2025: 2,056.7 1,773.8 kg/ha), whereas visual wilting scores failed to distinguish yield-retaining genotypes. Overall, UAV-based high-throughput phenotyping offers a robust and yield-relevant alternative to visual wilting scores, supporting the development of drought-tolerant soybean germplasm and cultivars. - Source: PubMed
Publication date: 2026/06/02
Pawar Popat ShivajiWu ChengjunHarrison DerrickRogers DanielFallen BenCanella Vieira Caio